Skip to main content
. 2017 Sep 23;8(57):97079–97089. doi: 10.18632/oncotarget.21226

Table 2B. Curative effect in different groups.

Group N Excellent Effective Invalid R
BSP 100 35 47 18 0.6644
control 100 0 25 75 0.3356